Profile data is unavailable for this security.
About the company
Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.
- Revenue in INR (TTM)20.09bn
- Net income in INR3.92bn
- Incorporated2007
- Employees3.55k
- LocationEris Lifesciences Ltd7th Floor, Commerce House IV,,Beside Shell Petrol Pump, 100 Feet Road,AHMEDABAD 380054IndiaIND
- Phone+91 7 969661000
- Fax+91 7 930179404
- Websitehttps://eris.co.in/
More ▼
Mergers & acquisitions
| Acquired company | ERIS:NSI since announced | Transaction value |
|---|---|---|
| Biocon Biologics Ltd-BFI Business | 33.66% | 149.96m |
| Swiss Parenterals Ltd | 23.11% | 76.84m |
| Biocon Biologics Ltd - Dermatology And Nephrology Business Units | 28.50% | 43.98m |
Data delayed at least 15 minutes, as of Jul 29 2024 09:04 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Advanced Research Co Ltd | 755.45m | -3.87bn | 73.56bn | 409.00 | -- | 58.49 | -- | 97.37 | -11.93 | -11.93 | 2.33 | 3.88 | 0.1123 | 22.11 | 2.32 | 1,847,073.00 | -57.57 | -61.70 | -85.94 | -119.31 | 62.76 | 74.49 | -512.56 | -163.40 | 1.01 | -244.66 | 0.3272 | -- | -68.36 | -16.21 | -73.96 | -- | 15.40 | -- |
| Blue Jet Healthcare Ltd | 7.12bn | 1.64bn | 77.43bn | -- | 47.27 | 9.16 | 40.36 | 10.88 | 9.44 | 9.44 | 41.04 | 48.73 | 0.7409 | 2.46 | 3.42 | -- | 17.05 | -- | 21.25 | -- | 55.82 | -- | 23.01 | -- | 2.80 | 1,257.13 | 0.00 | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| F D C Ltd | 19.43bn | 3.05bn | 81.75bn | 6.37k | 26.98 | 3.90 | 23.70 | 4.21 | 18.61 | 18.61 | 118.69 | 128.81 | 0.8077 | 1.83 | 16.19 | -- | 12.68 | 12.05 | 14.56 | 13.73 | 66.23 | 62.81 | 15.70 | 15.85 | 2.18 | 74.02 | 0.0097 | -- | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
| Procter & Gamble Health Ltd | 11.69bn | 2.14bn | 86.88bn | 1.41k | 40.62 | -- | 36.08 | 7.43 | 128.85 | 128.85 | 703.49 | -- | -- | -- | -- | 8,305,331.00 | -- | -- | -- | -- | 70.45 | -- | 18.31 | -- | -- | 400.33 | -- | -- | 10.34 | -- | 19.19 | -- | -- | -- |
| Marksans Pharma Ltd | 21.77bn | 3.14bn | 90.78bn | 1.40k | 28.91 | 4.40 | 23.33 | 4.17 | 6.93 | 6.93 | 48.11 | 45.57 | 0.894 | 1.88 | 5.01 | -- | 12.93 | 14.62 | 15.36 | 18.52 | 52.32 | 51.22 | 14.46 | 14.03 | 3.19 | 34.30 | 0.1048 | 6.66 | 17.56 | 16.84 | 17.80 | 32.62 | 73.86 | 64.38 |
| Strides Pharma Science Ltd | 40.51bn | -1.25bn | 93.90bn | 2.85k | -- | 4.42 | 130.15 | 2.32 | -13.86 | -7.93 | 445.06 | 231.29 | 0.6493 | 1.44 | 3.32 | -- | -2.38 | -1.68 | -4.43 | -2.97 | 59.50 | 52.74 | -3.67 | -3.36 | 0.64 | 1.07 | 0.5485 | -- | 9.83 | 13.21 | 43.57 | -- | -18.52 | -3.58 |
| Glenmark Life Sciences Ltd | 22.93bn | 4.47bn | 104.23bn | 1.82k | 23.36 | -- | 20.76 | 4.54 | 36.41 | 36.41 | 186.83 | -- | -- | -- | -- | -- | -- | 18.28 | -- | 30.03 | 54.58 | 53.40 | 19.49 | 20.23 | -- | 389.45 | -- | -- | 5.64 | 20.83 | 0.841 | 19.21 | 69.11 | -- |
| Neuland Laboratories Ltd. | 15.59bn | 3.00bn | 107.48bn | 1.65k | 35.82 | 8.38 | 29.87 | 6.90 | 233.89 | 233.89 | 1,214.81 | 999.78 | 0.9135 | 2.33 | 4.24 | 9,457,406.00 | 17.59 | 9.25 | 23.58 | 12.71 | 52.92 | 47.81 | 19.25 | 11.99 | 1.33 | 28.78 | 0.0692 | 7.13 | 30.84 | 18.51 | 83.51 | 78.76 | 17.88 | 63.45 |
| Jubilant Pharmova Ltd | 68.48bn | 5.53bn | 114.73bn | 1.03k | 20.77 | -- | 12.32 | 1.68 | 34.89 | 34.89 | 431.45 | -- | -- | -- | -- | -- | -- | 2.96 | -- | 3.55 | 68.13 | 69.37 | 8.01 | 5.13 | -- | 2.34 | -- | 24.69 | 6.70 | -5.95 | 226.43 | -33.08 | 6.48 | 2.13 |
| Caplin Point Laboratories Ltd | 16.94bn | 4.57bn | 116.10bn | 777.00 | 25.50 | 5.01 | 22.55 | 6.85 | 59.90 | 59.90 | 222.01 | 304.93 | 0.6931 | 2.22 | 3.62 | -- | 18.88 | 19.83 | 21.80 | 22.82 | 57.25 | 53.99 | 27.24 | 25.39 | 4.63 | 976.47 | 0.0008 | -- | 15.50 | 21.17 | 21.48 | 20.95 | 17.47 | -- |
| Wockhardt Ltd | 27.98bn | -4.63bn | 130.90bn | 2.39k | -- | 3.90 | -- | 4.68 | -32.08 | -32.08 | 194.04 | 218.97 | 0.365 | 1.80 | 3.95 | 11,687,550.00 | -6.16 | -4.56 | -11.11 | -8.29 | 58.36 | 55.26 | -16.87 | -12.70 | 0.5532 | -0.1594 | 0.3915 | -- | 5.55 | -4.73 | 17.17 | -- | -4.71 | -- |
| Granules India Ltd | 45.06bn | 4.05bn | 136.48bn | 4.12k | 33.67 | 4.23 | 22.28 | 3.03 | 16.72 | 16.72 | 185.99 | 133.08 | 0.8645 | 1.60 | 4.66 | 10,932,480.00 | 7.78 | 10.68 | 12.41 | 16.18 | 55.15 | 48.83 | 8.99 | 11.82 | 0.7444 | 6.13 | 0.2896 | 8.96 | -0.123 | 14.61 | -21.54 | 11.38 | 6.38 | 8.45 |
| Eris Lifesciences Ltd | 20.09bn | 3.92bn | 146.08bn | 3.55k | 37.30 | 5.65 | 25.20 | 7.27 | 28.78 | 28.78 | 147.52 | 190.12 | 0.375 | 2.37 | 5.62 | -- | 7.41 | 13.42 | 11.22 | 16.80 | 81.08 | 80.29 | 19.76 | 24.96 | 0.8345 | 5.80 | 0.4633 | -- | 19.23 | 15.39 | 2.57 | 6.15 | 27.72 | -- |
| Sanofi India Ltd | 28.47bn | 5.49bn | 153.74bn | 2.17k | 28.00 | -- | 26.10 | 5.40 | 238.42 | 238.42 | 1,236.19 | -- | -- | -- | -- | 13,095,680.00 | -- | 22.42 | -- | 30.21 | 57.68 | 55.52 | 19.29 | 21.03 | -- | 442.82 | -- | 135.49 | 2.92 | 0.573 | -2.85 | 9.64 | -10.34 | 14.73 |
| Concord Biotech Ltd | 10.17bn | 3.08bn | 178.12bn | 1.38k | 57.84 | 11.67 | 49.25 | 17.52 | 29.44 | 29.44 | 97.17 | 145.93 | -- | -- | -- | 7,385,180.00 | -- | -- | -- | -- | 77.46 | -- | 30.30 | -- | 4.84 | -- | 0.0063 | -- | 19.20 | -- | 28.33 | -- | -- | -- |
| Astrazeneca Pharma India Ltd | 12.96bn | 1.62bn | 179.32bn | 940.00 | 111.02 | 25.19 | 101.62 | 13.84 | 64.60 | 64.60 | 518.21 | 284.77 | 1.26 | 2.84 | 9.79 | 13,782,230.00 | 15.66 | 11.78 | 24.44 | 19.62 | 54.11 | 54.64 | 12.47 | 10.27 | 1.97 | 141.26 | 0.0064 | 25.62 | 29.17 | 12.21 | 62.66 | 24.29 | -10.46 | -- |
Data as of Jul 29 2024. Currency figures normalised to Eris Lifesciences Ltd's reporting currency: Indian Rupee INR
16.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 15 Dec 2023 | 6.98m | 5.13% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 03 May 2024 | 6.78m | 4.98% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 28 Jun 2024 | 1.99m | 1.46% |
| Templeton Asset Management Ltd.as of 28 Jun 2024 | 1.78m | 1.31% |
| Plutus Wealth Management LLPas of 30 Sep 2023 | 1.50m | 1.10% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Jun 2024 | 848.88k | 0.62% |
| Tata AIA Life Insurance Co. Ltd.as of 30 Jun 2024 | 848.42k | 0.62% |
| Bank of India Investment Managers Pvt Ltd.as of 30 Jun 2024 | 550.85k | 0.41% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 425.65k | 0.31% |
| Bandhan Asset Management Co. Ltd.as of 30 Jun 2024 | 264.36k | 0.19% |
More ▼
Data from 31 Mar 2024 - 15 Jul 2024Source: FactSet Research Systems Inc.
